- Home
- RIGL vs HVT Comparison
RIGL vs HVT Comparison
Compare RIGL & HVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- HVT
- Stock Information
- Founded
- RIGL 1996
- HVT 1885
- Country
- RIGL United States
- HVT United States
- Employees
- RIGL N/A
- HVT N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- HVT Other Specialty Stores
- Sector
- RIGL Health Care
- HVT Consumer Discretionary
- Exchange
- RIGL Nasdaq
- HVT Nasdaq
- Market Cap
- RIGL 335.5M
- HVT 329.5M
- IPO Year
- RIGL 2000
- HVT N/A
- Fundamental
- Price
- RIGL $41.50
- HVT $23.38
- Analyst Decision
- RIGL Buy
- HVT
- Analyst Count
- RIGL 5
- HVT 0
- Target Price
- RIGL $38.20
- HVT N/A
- AVG Volume (30 Days)
- RIGL 845.0K
- HVT 94.3K
- Earning Date
- RIGL 08-05-2025
- HVT 07-30-2025
- Dividend Yield
- RIGL N/A
- HVT 5.75%
- EPS Growth
- RIGL N/A
- HVT N/A
- EPS
- RIGL 5.43
- HVT 1.17
- Revenue
- RIGL $267,921,000.00
- HVT $722,858,000.00
- Revenue This Year
- RIGL $14.41
- HVT $3.51
- Revenue Next Year
- RIGL $15.97
- HVT $8.93
- P/E Ratio
- RIGL $7.64
- HVT $19.93
- Revenue Growth
- RIGL 105.62
- HVT N/A
- 52 Week Low
- RIGL $12.00
- HVT $17.01
- 52 Week High
- RIGL $43.72
- HVT $28.53
- Technical
- Relative Strength Index (RSI)
- RIGL 86.20
- HVT 63.19
- Support Level
- RIGL $38.43
- HVT $21.84
- Resistance Level
- RIGL $41.25
- HVT $23.19
- Average True Range (ATR)
- RIGL 2.50
- HVT 0.67
- MACD
- RIGL 0.89
- HVT 0.12
- Stochastic Oscillator
- RIGL 89.85
- HVT 95.71
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About HVT Haverty Furniture Companies Inc.
Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.